Lorenzo Ridola

Pubblicazioni

Titolo Pubblicato in Anno
Old and New Precipitants in Hepatic Encephalopathy: A New Look at a Field in Continuous Evolution JOURNAL OF CLINICAL MEDICINE 2023
Hepatic encephalopathy increases the risk for mortality and hospital readmission in decompensated cirrhotic patients: a prospective multicenter study FRONTIERS IN MEDICINE 2023
Comment to: “TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis.” JOURNAL OF HEPATOLOGY 2023
Application of ultrasonography-elastography score to suspect porto-sinusoidal vascular disease in patients with portal vein thrombosis HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL 2023
Porto-sinusoidal vascular disorder (PSVD): application of new diagnostic criteria in a multicenter cohort of patients DIGESTIVE AND LIVER DISEASE 2023
Use of albumin infusion for cirrhosis-related complications: An international position statement JHEP REPORTS 2023
Association between gut-derived endotoxins and porto-sinusoidal vascular disorder with portal hypertension ALIMENTARY PHARMACOLOGY AND THERAPEUTICS 2023
The Management of Hepatic Encephalopathy from Ward to Domiciliary Care: Current Evidence and Gray Areas JOURNAL OF CLINICAL MEDICINE 2023
Transjugular Intrahepatic Portosystemic Shunt Placement: Effects on Nutritional Status in Cirrhotic Patients JOURNAL OF CLINICAL MEDICINE 2023
Primary Prophylaxis of Overt Hepatic Encephalopathy: Is It Time to Consider It? JOURNAL OF CLINICAL MEDICINE 2023
Albumin for cognitive impairment after TIPS: A road to be explored JOURNAL OF HEPATOLOGY 2023
Episodic overt hepatic encephalopathy after transjugular intrahepatic portosystemic shunt does not increase mortality in patients with cirrhosis JOURNAL OF HEPATOLOGY 2023
Clinical outcomes and prognostic factors in non-cirrhotic non-neoplastic patients with portal vein thrombosis: A single-centre experience DIGESTIVE AND LIVER DISEASE 2023
Prevention of post-tips hepatic encephalopathy: The search of the ideal candidate METABOLIC BRAIN DISEASE 2023
Hepatic encephalopathy – recent advances in treatment and diagnosis EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY 2023
Ammonia and the muscle: an emerging point of view on hepatic encephalopathy JOURNAL OF CLINICAL MEDICINE 2022
Risk factors for hepatic encephalopathy and mortality in cirrhosis: the role of cognitive impairment, muscle alterations and shunts: predictors of HE DIGESTIVE AND LIVER DISEASE 2022
Cognitive impairement in non-cirrhotic portal hypertension: Highlights on physiopathology, diagnosis and management JOURNAL OF CLINICAL MEDICINE 2022
Editorial: infections and hepatic encephalopathy–does the chicken or the egg come FIRST? A novel perspective at the horizon ALIMENTARY PHARMACOLOGY & THERAPEUTICS 2022
Gut liver muscle brain axis: A comprehensive viewpoint on prognosis in cirrhosis JOURNAL OF HEPATOLOGY 2022

ERC

  • LS4_13

Interessi di ricerca

Il principale campo di ricerca del Dott. Lorenzo Ridola riguarda le epatopatie croniche, la cirrosi con le conseguenze della grave insufficienza epatica e le neoplasie primitive del fegato.  In quest’ambito, utilizzando metodiche cliniche e sperimentali e con spiccata vocazione traslazionale, il Dott. Ridola si concentra su: 1) patogenesi, strategie diagnostiche e terapeutiche dell’encefalopatia epatica minima e manifesta, 2) valutazione e patogenesi delle alterazioni nutrizionali del cirrotico, 3) terapia delle epatopatie evolute e delle complicanze dell’ipertensione portale, 4) nuove strategie terapeutiche delle epatopatie colestatiche autoimmuni e neoplastiche, anche partecipando al disegno, al coordinamento ed alla conduzione di trials clinici randomizzati controllati. Un altro filone di ricerca del Dott. Ridola è rappresentato dalle patologie del tubo digerente ed in particolare l’attenzione si è focalizzata: 1) sulle lesioni preneoplastiche del tubo digerente superiore e le strategie terapeutiche dell’infezione da H. pylori, 2) sulle strategie di screening del cancro colorettale e la terapia endoscopica delle lesioni preneoplastiche e 3) sulle malattie infiammatorie croniche intestinali. Il Dott. Ridola collabora attivamente con gruppi nazionali (Roma, Bologna, Padova) ed internazionali (Aarhus-Danimarca e Richmond-USA). L’attività di ricerca e di coordinazione di gruppi di ricerca, svolta anche in qualità di componente del comitato scientifico di società scientifiche nazionali, è documentata dai lavori in collaborazione pubblicati e dalle relazioni svolte a convegni nazionali ed internazionali.

Keywords

cirrhosis
Portal hypertension
cognitive impairment
primary liver cancer

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma